This randomized clinical trial determines whether nab-paclitaxel improves the outcomes of early and locally advanced ERBB2/HER2-negative breast cancer compared with paclitaxel when delivered in a neoadjuvant setting.
This cohort analysis examined 3-year recurrence-free survival in patients with varying levels of preoperative and postoperative carcinoembryonic antigen.
This population-based study of data from the California Cancer Registry examines trends in cancer survival by health insurance status from January 1997 to December 2014.
This study examined the American Society of Clinical Oncology’s value framework for awarding bonus points to immuno-oncology agents for durable long-term survival.
This population-based, case-control study examines the relative and absolute risks of breast anaplastic large-cell lymphoma in women with breast implants.
This systematic review and meta-analysis reviews phase 3 randomized clinical trials of high-dose therapy followed by autologous stem cell transplant in patients with multiple myeloma.
This cohort study investigates whether the pretreatment derived neutrophils/(leukocytes minus neutrophils) ratio and lactate dehydrogenase level are associated with resistance to immunotherapy in patients with advanced non–small cell lung cancer.
This nested case-control study uses 2 large US cohorts to examine the association of the oral microbiome with subsequent risk of head and neck squamous cell cancer.
This cohort study followed participants for 26 years to determine whether proinflammatory diets are associated with increased colorectal cancer risk.
This systematic review with meta-analysis examines the rates of cardiovascular adverse events among patients receiving carfilzomib for the treatment of multiple myeloma.
This medical record review evaluates the relation of immune-related adverse events to nivolumab efficacy in non–small-cell lung cancer.
This pooled analysis of 2 randomized clinical trials evaluates the association of DNA mismatch repair status with disease-free survival in patients with stage III colon cancer treated with FOLFOX.
This analysis of data from an open-label, nonrandomized, multicohort study of patients from the VE-BASKET trial evaluates the efficacy and safety of vemurafenib in the treatment of adults with BRAF V600–mutant Erdheim-Chester disease or Langerhans cell histiocytosis.
This study examines the protein expression and DNA alteration for the KRAS, CDKN2A, SMAD4, and TP53 main driver genes to determine their association with patient outcomes after pancreatic cancer surgical resection.
This study examines the lack of race-adjusted measurements for renal function in eligibility criteria for participation of black men in prostate cancer trials.
This population-based cohort study examines the association of radiotherapy for Hodgkin lymphoma with risk of ER-positive and ER-negative breast cancers using data from the US National Cancer Institute Surveillance, Epidemiology, and End Results database.
This study examines the association of accessing electronic oncology patient portal data with patient characteristics and type of portal content.
This review examines the prognostic value of minimal residual disease status in patients with chronic lymphocytic leukemia undergoing treatment with novel therapeutics.
A man in his 20s presented with a 2-month history of vague right upper quadrant abdominal pain, 5-kg weight loss, loss of appetite, and increasing abdominal distension. What is your diagnosis?
This Viewpoint examines the financial burden of medical school for aspiring oncologists from underrepresented backgrounds and suggests potential programs to help alleviate the financial burden.
This Viewpoint examines the generalizability of the results of ProtecT Trial to minority populations.
This commentary discusses a study in JAMA that compared the ability of machine learning algorithms vs clinical pathologists to detect cancer metastases in whole-slide images of axillary lymph nodes dissected from women with breast cancer.
Create a personal account or sign in to: